Clinical Trial Update: To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is planned to study a generic fluticasone propionate inhalation aerosol for bronchial asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• Fluticasone Propionate Inhalation Aerosol (fluticasone propionate)

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Bronchial Asthma | Phase 3 | Status: UNKNOWN